Glypican 1 (GPC1) levels on pancreatic cancer-derived sEVs indicated cancer burden in patients before and after surgery, exhibiting significant diagnostic and predictive potentials (96, 109). This evidence concerns the gene GPC1 and familial pancreatic carcinoma.